Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

5029 total record number 57 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 6 out of 503
5029 citations found

Anti-Inflammatory Effects of Clarstatin, a Shared-Epitope-Antagonistic Cyclic Peptide, on Experimental Autoimmune Uveitis in Mice

Merzbach, S;Schumacher?Klinger, A;Klazas, M;Hoffman, A;Lazarovici, P;Gilon, C;Nussbaum, G;Amer, R;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Tumor initiating cells escape tumor immunity via CCL8 from tumor-associated macrophages in mice

Chen, S;Huang, CS;Li, K;Cheng, M;Zhang, C;Xiong, J;Tian, G;Zhou, R;Ling, R;Wang, X;Xiong, G;Zhang, Z;Ma, J;Zhu, Y;Zhou, B;Peng, L;Peng, Z;Li, H;Chen, D;

Product: Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae

Development of a Recombinant Fusion Vaccine Candidate Against Lethal Clostridium botulinum Neurotoxin Types A and B

Choi, E;Pyo, S;Kim, S;Jeon, J;Rhie, G;Yun, M;Yi, H;Chung, Y;

Product: Botulinum Neurotoxin Type B Complex, Nicked, from Clostridium botulinum

  • 2.4. Preparation of Toxins

    BoNT/A was harvested from C. botulinum strain ATCC19397 following a 6-day anaerobic culture as described previously [18,19]. BoNT/B complex was purchased from List Bio Laboratory Inc. (Campbell, CA, USA). The potencies of the toxins were determined using standard mouse bioassays with established LD50 values for BoNT/A and B. The LD50 values of BoNT/A and B in mice were confirmed to be 0.1 ng and 0.18 ng, respectively.

Fluorescence-barcoded cell lines stably expressing membrane-anchored influenza neuraminidases

Finney, J;Kuraoka, M;Song, S;Watanabe, A;Liang, X;Liao, D;Moody, MA;Walter, EB;Harrison, SC;Kelsoe, G;

Product: Tetanus Toxoid from Clostridium tetani

  • Luminex multiplex binding assay

    The specificities and avidities of clonal IgGs in culture supernatants were determined in a multiplex bead assay (Luminex Corp.) as described (25, 44) with modifications. Culture supernatants were diluted in Luminex assay buffer (phosphate-buffered saline [PBS] containing 1% bovine serum albumin [BSA], 0.05% NaN3, and 0.05% Tween 20) with 1% milk and incubated for 2_h with the mixture of antigen-coupled microsphere beads in 96-well filter-bottom plates (Millipore). After washing three times with assay buffer, the beads were incubated for 1_h with PE-conjugated mouse anti-human IgG Abs (JDC-10; Southern Biotech). After three washes, the beads were resuspended in assay buffer and the plates read on a Bio-Plex 3D suspension array system (Bio-Rad). Antigens and controls included BSA, mouse anti-human Ig(κ) (SB81a; Southern Biotech), mouse anti-human Ig(λ) (JDC-12; Southern Biotech), mouse anti-human IgG (Jackson ImmunoResearch), tetanus toxoid from Clostridium tetani (List Biological Laboratories), …

    Product #191 – Tetanus Toxoid from Clostridium tetani

Discovery of Novel Nlrp3 Inhibitors Enabled by a High-Throughput Screen

Dorich, S;Auger, A;Wang, L;Burch, J;Pellerin, C;Chan, S;Raymond, M;Zhang, L;Chefson, A;Germain, M;Jananji, S;Dumais, V;Gaudreault, S;Caron, A;Dumas-Bérube, É;Crackower, M;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

  • NLRC4 Activity in Human Monocytes

    A 10-µL aliquot of compound (10X in 1% DMSO) was added to PMA-differentiated THP1-Null2 cells (65,000 cells in 80 µL of RPMI media per well) and incubated for 60 minutes in a humidified incubator at 37°C with 5% CO2. NLRC4 activation was initiated by adding a 10 µL mixture of LFnNeedle and B. anthracis protective antigen (PA) (List Labs #171E) (10X). LFn-Needle is fused to the amino-terminal domain of LFn (in house). This fusion system, when co-administered with the anthrax toxin’s PA, allows intracellular delivery of the bacterial ligand [11]. OptiMEM (10 µL) was added to control wells in lieu of LFnNeedle/PA treatment. The plate was incubated for 5 hours in a humidified incubator at 37°C with 5% CO2.

    Product #171E – Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Decreased lymph node estrogen levels cause nonremitting progressive experimental autoimmune encephalomyelitis disease

Anwar, S;Lin, PP;Pacheco, L;Imai, K;Tan, Z;Song, Z;Wakamatsu, Y;Minamiya, Y;Cheng, J;Ko, C;Inoue, M;

Product: Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)

  • Reagents

    Pertussis toxin (181) was purchased from List Biological. …

    Induction of active EAE

    In 6- to 8-week-old mice, EAE was induced by s.c. injection of myelin oligodendrocyte glycoprotein 35–55 peptide (100 µg/mouse) emulsified in complete Freund’s adjuvant including heat-killed Mycobacterium tuberculosis (200 µg/mouse) on day 0, along with intraperitoneal (i.p.) injection of pertussis toxin (200 µg/mouse) on days 0 and 2. …

    Product #181 – Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)

Senolytic Targeting of Anti-Apoptotic Bcl Family Increases Cell Death in UV-Irradiated Senescent Melanocytes: Search for Senolytics

Kim, JC;Kim, NY;Kim, Y;Baek, DJ;Park, TJ;Kang, HY;

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

DAG-MAG-ΒHB: A Novel Ketone Diester Modulates NLRP3 Inflammasome Activation in Microglial Cells in Response to Beta-Amyloid and Low Glucose AD-like Conditions

Gentili, V;Schiuma, G;Dilliraj, L;Beltrami, S;Rizzo, S;Lara, D;Giovannini, P;Marti, M;Bortolotti, D;Trapella, C;Narducci, M;Rizzo, R;

Product: Anthrax Lethal Factor (LF), Recombinant from B. anthracis

  • 2.13. Priming of Inflammasomes

    Inflammasome activation was measured according to Primiano et al.’s description [28]. HCM3 cells were plated in EMEM without supplements at 1 × 105 cells/well. Cells were stimulated for 1 h with 10 g/mL (13.4 mM) of nigericin (tlrl-nig, InvivoGen, San Diego, CA, USA) for 2 h with 2 mM ATP (tlrl-atpl, InvivoGen), or overnight with 200 g/mL of monosodium urate crystals (MSU; tlrl-msu, InvivoGen) for NLRP3 induction; flagellin/DOTAP complex, obtained with 25 μL HBS buffer with 500 ng flagellin (final concentration at 1 μg/mL; tlrl-stfla, InvivoGen) and 3 μL DOTAP (11202375001, Sigma-Aldrich) for each well for NLRC4 induction; with 0.5 mL Opti-MEM supplemented with GlutaMax (Opti-MEM™ Reduced Serum Medium containing GlutaMAX™ Supplement, 51985034, Gibco, Grand Island, NY, USA) containing 1 μg/mL Bacillus anthracis lethal factor (172B, List Biological Laboratories, Campbell, CA, USA) for 3–6 h for NLRP1 induction; and with a poly(dA:dT)/lipofectamine complex, obtained by mixing 50 μL Opti-MEM containing 1 μg poly(dA:dT) (final concentration at 2 μg/mL) with 50 μL Opti-MEM containing 2.5 μL lipofectamine 2000 (11668027, Thermo Fisher’s Scientific, Waltham, MA, USA) for each well for AIM2 induction. …

    Product #172 – Anthrax Lethal Factor (LF), Recombinant from B. anthracis

A core glycolipid vaccine elicits cross-reactive antibodies against Salmonella spp. and protects against invasive nontyphoidal Salmonella disease in mice

Baliban, SM;Shridhar, S;Luo, K;Kolasny, J;Hyun, S;Zhao, Z;Tennant, SM;Cross, AS;

Product: LPS from Escherichia coli O111:B4

  • … with 20 mg of D-galactosamine (DGalN, MilliporeSigma), to sensitize them to the biological effects of endotoxin, and simultaneously challenged with 5 ng of E. coli O111:B4 LOS (List Biological Laboratories, Campbell, CA) [23]. …

    Product #201 – LPS from Escherichia coli O111:B4

NET formation-mediated in situ protein delivery to the inflamed central nervous system

Wu, Y;Park, J;Le, Q;Byun, J;Choi, J;Xu, H;Lee, J;Oh, Y;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

  • Biodistribution study of nanoparticles in EAE mouse model

    The biodistribution of nanoparticles was assessed in the EAE mouse model. Female C57BL/6 mice (11 weeks old) were subcutaneously injected with 200 μg of MOG35-55 peptide (2 mg/mL, Prospec, Rehovot, Israel, cat# PRO-371), emulsified with an equal volume of Complete-Freund’s adjuvant (CFA) (Chondrex, Woodinville, WA, USA, cat# 7001), consisting of 4 mg/mL of heat-killed M. Tuberculosis H37 RA. Subsequently, the mice received 400 ng of Pertussis toxin (PTX) (List Biological Labs, Campbell, CA, USA, cat# 180) intraperitoneally at 2 and 24 h post-injection of the emulsion. Intravenous injection of Cy5-labeled nanoparticles at a dose of 40 mg per kg was performed on day 12 post-immunization. The fluorescence of nanoparticles in the brain, spinal cord, and major organs was assessed using an IVIS spectrum In Vivo Imaging System (PerkinElmer) at various time points post-injection. …

    Author did not specify which List Labs Pertussis Toxin was utilized. List Labs provides the following Pertussis Toxin products:
    Product #180 – Pertussis Toxin from B. pertussis, Lyophilized in Buffer
    Product #181 – Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)
    Product #179A – Pertussis Toxin from B. pertussis (in Glycerol)